Echocardiographic Assessment of Cardiac Structural and Functional Abnormalities in Patients With End-Stage Renal Disease Receiving Chronic Hemodialysis

Background:The aim of this study was to assess the echocardiographic characteristics of chronic hemodialysis (HD) patients with end-stage renal disease (ESRD) in a multicenter prospective cohort study.Methods and Results:Three hundred and fifteen patients with ESRD (67.9±10.6 years, 47.6% male) on c...

Full description

Saved in:
Bibliographic Details
Published inCirculation Journal Vol. 82; no. 2; pp. 586 - 595
Main Authors Matsuo, Hiroshi, Dohi, Kaoru, Machida, Hirofumi, Takeuchi, Hideyuki, Aoki, Toshikazu, Nishimura, Hiroyuki, Yasutomi, Masashi, Senga, Michiharu, Ichikawa, Takehiko, Kakuta, Kentaro, Mizutani, Yasuhide, Tanoue, Akiko, Isaka, Naoki, Oosugi, Kazuki, Koyabu, Sukenari, Sakurai, Masato, Fukui, Yoshihisa, Kakimoto, Hitoshi, Sugimoto, Tadafumi, Ohnishi, Takahiro, Murata, Tomohiro, Ishikawa, Eiji, Okamoto, Ryuji, Yamada, Tomomi, Ogura, Toru, Nishimura, Yuki, Tanigawa, Takashi, Nomura, Shinsuke, Nishikawa, Masakatsu, Ito, Masaaki
Format Journal Article
LanguageEnglish
Published Japan The Japanese Circulation Society 25.01.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background:The aim of this study was to assess the echocardiographic characteristics of chronic hemodialysis (HD) patients with end-stage renal disease (ESRD) in a multicenter prospective cohort study.Methods and Results:Three hundred and fifteen patients with ESRD (67.9±10.6 years, 47.6% male) on chronic HD for ≥1 year were examined on transthoracic echocardiography, including Doppler-derived aortic valve area (AVA) measurement. Only 11.5% and 3.4% of all patients had normal left ventricular (LV) geometry and normal LV filling pattern, respectively. The majority of patients had aortic and mitral valvular calcification, and approximately 50% of all 315 patients had aortic valve narrowing with AVA <2.0 cm2. Patients were divided into 3 groups according to AVA index tertile: group 1, highest tertile; group 2, middle tertile; and group 3, lowest tertile. Group 3 was older, had a greater cardiothoracic ratio on chest X-ray, higher plasma brain natriuretic peptide and total LV afterload, and lower stroke volume index than the other 2 groups. Age and intact parathyroid hormone (PTH) level were independently associated with low AVA index.Conclusions:Patients with ESRD on chronic HD have a high prevalence of cardiac structural and functional abnormalities including calcified aortic sclerosis. High age and PTH were associated with aortic valve narrowing in these patients.
AbstractList The aim of this study was to assess the echocardiographic characteristics of chronic hemodialysis (HD) patients with end-stage renal disease (ESRD) in a multicenter prospective cohort study. Three hundred and fifteen patients with ESRD (67.9±10.6 years, 47.6% male) on chronic HD for ≥1 year were examined on transthoracic echocardiography, including Doppler-derived aortic valve area (AVA) measurement. Only 11.5% and 3.4% of all patients had normal left ventricular (LV) geometry and normal LV filling pattern, respectively. The majority of patients had aortic and mitral valvular calcification, and approximately 50% of all 315 patients had aortic valve narrowing with AVA <2.0 cm . Patients were divided into 3 groups according to AVA index tertile: group 1, highest tertile; group 2, middle tertile; and group 3, lowest tertile. Group 3 was older, had a greater cardiothoracic ratio on chest X-ray, higher plasma brain natriuretic peptide and total LV afterload, and lower stroke volume index than the other 2 groups. Age and intact parathyroid hormone (PTH) level were independently associated with low AVA index. Patients with ESRD on chronic HD have a high prevalence of cardiac structural and functional abnormalities including calcified aortic sclerosis. High age and PTH were associated with aortic valve narrowing in these patients.
The aim of this study was to assess the echocardiographic characteristics of chronic hemodialysis (HD) patients with end-stage renal disease (ESRD) in a multicenter prospective cohort study.BACKGROUNDThe aim of this study was to assess the echocardiographic characteristics of chronic hemodialysis (HD) patients with end-stage renal disease (ESRD) in a multicenter prospective cohort study.Three hundred and fifteen patients with ESRD (67.9±10.6 years, 47.6% male) on chronic HD for ≥1 year were examined on transthoracic echocardiography, including Doppler-derived aortic valve area (AVA) measurement. Only 11.5% and 3.4% of all patients had normal left ventricular (LV) geometry and normal LV filling pattern, respectively. The majority of patients had aortic and mitral valvular calcification, and approximately 50% of all 315 patients had aortic valve narrowing with AVA <2.0 cm2. Patients were divided into 3 groups according to AVA index tertile: group 1, highest tertile; group 2, middle tertile; and group 3, lowest tertile. Group 3 was older, had a greater cardiothoracic ratio on chest X-ray, higher plasma brain natriuretic peptide and total LV afterload, and lower stroke volume index than the other 2 groups. Age and intact parathyroid hormone (PTH) level were independently associated with low AVA index.METHODS AND RESULTSThree hundred and fifteen patients with ESRD (67.9±10.6 years, 47.6% male) on chronic HD for ≥1 year were examined on transthoracic echocardiography, including Doppler-derived aortic valve area (AVA) measurement. Only 11.5% and 3.4% of all patients had normal left ventricular (LV) geometry and normal LV filling pattern, respectively. The majority of patients had aortic and mitral valvular calcification, and approximately 50% of all 315 patients had aortic valve narrowing with AVA <2.0 cm2. Patients were divided into 3 groups according to AVA index tertile: group 1, highest tertile; group 2, middle tertile; and group 3, lowest tertile. Group 3 was older, had a greater cardiothoracic ratio on chest X-ray, higher plasma brain natriuretic peptide and total LV afterload, and lower stroke volume index than the other 2 groups. Age and intact parathyroid hormone (PTH) level were independently associated with low AVA index.Patients with ESRD on chronic HD have a high prevalence of cardiac structural and functional abnormalities including calcified aortic sclerosis. High age and PTH were associated with aortic valve narrowing in these patients.CONCLUSIONSPatients with ESRD on chronic HD have a high prevalence of cardiac structural and functional abnormalities including calcified aortic sclerosis. High age and PTH were associated with aortic valve narrowing in these patients.
Background:The aim of this study was to assess the echocardiographic characteristics of chronic hemodialysis (HD) patients with end-stage renal disease (ESRD) in a multicenter prospective cohort study.Methods and Results:Three hundred and fifteen patients with ESRD (67.9±10.6 years, 47.6% male) on chronic HD for ≥1 year were examined on transthoracic echocardiography, including Doppler-derived aortic valve area (AVA) measurement. Only 11.5% and 3.4% of all patients had normal left ventricular (LV) geometry and normal LV filling pattern, respectively. The majority of patients had aortic and mitral valvular calcification, and approximately 50% of all 315 patients had aortic valve narrowing with AVA <2.0 cm2. Patients were divided into 3 groups according to AVA index tertile: group 1, highest tertile; group 2, middle tertile; and group 3, lowest tertile. Group 3 was older, had a greater cardiothoracic ratio on chest X-ray, higher plasma brain natriuretic peptide and total LV afterload, and lower stroke volume index than the other 2 groups. Age and intact parathyroid hormone (PTH) level were independently associated with low AVA index.Conclusions:Patients with ESRD on chronic HD have a high prevalence of cardiac structural and functional abnormalities including calcified aortic sclerosis. High age and PTH were associated with aortic valve narrowing in these patients.
Author Kakuta, Kentaro
Tanoue, Akiko
Fukui, Yoshihisa
Senga, Michiharu
Yamada, Tomomi
Nomura, Shinsuke
Isaka, Naoki
Ito, Masaaki
Matsuo, Hiroshi
Sugimoto, Tadafumi
Ogura, Toru
Aoki, Toshikazu
Ichikawa, Takehiko
Takeuchi, Hideyuki
Tanigawa, Takashi
Dohi, Kaoru
Nishimura, Yuki
Yasutomi, Masashi
Nishimura, Hiroyuki
Mizutani, Yasuhide
Machida, Hirofumi
Ishikawa, Eiji
Koyabu, Sukenari
Sakurai, Masato
Ohnishi, Takahiro
Murata, Tomohiro
Okamoto, Ryuji
Nishikawa, Masakatsu
Oosugi, Kazuki
Kakimoto, Hitoshi
Author_xml – sequence: 1
  fullname: Matsuo, Hiroshi
  organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine
– sequence: 2
  fullname: Dohi, Kaoru
  organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine
– sequence: 3
  fullname: Machida, Hirofumi
  organization: Department of Internal Medicine, Takeuchi Hospital
– sequence: 4
  fullname: Takeuchi, Hideyuki
  organization: Department of Internal Medicine, Takeuchi Hospital
– sequence: 5
  fullname: Aoki, Toshikazu
  organization: Department of Internal Medicine, Tohyama Hospital
– sequence: 6
  fullname: Nishimura, Hiroyuki
  organization: Department of Internal Medicine, Tohyama Hospital
– sequence: 7
  fullname: Yasutomi, Masashi
  organization: Department of Nephrology, Kuwana City Medical Center
– sequence: 8
  fullname: Senga, Michiharu
  organization: Department of Cardiology, Kuwana City Medical Center
– sequence: 9
  fullname: Ichikawa, Takehiko
  organization: Department of Cardiology, Kuwana City Medical Center
– sequence: 10
  fullname: Kakuta, Kentaro
  organization: Department of Cardiology, Yokkaichi Hazu Medical Center
– sequence: 11
  fullname: Mizutani, Yasuhide
  organization: Department of Nephrology, Yokkaichi Hazu Medical Center
– sequence: 12
  fullname: Tanoue, Akiko
  organization: Department of Internal Medicine, Murase Hospital
– sequence: 13
  fullname: Isaka, Naoki
  organization: Department of Internal Medicine, Murase Hospital
– sequence: 14
  fullname: Oosugi, Kazuki
  organization: Department of Internal Medicine, Owase General Hospital
– sequence: 15
  fullname: Koyabu, Sukenari
  organization: Department of Internal Medicine, Owase General Hospital
– sequence: 16
  fullname: Sakurai, Masato
  organization: Department of Internal Medicine, Saiseikai Matsusaka General Hospital
– sequence: 17
  fullname: Fukui, Yoshihisa
  organization: Department of Internal Medicine, Saiseikai Matsusaka General Hospital
– sequence: 18
  fullname: Kakimoto, Hitoshi
  organization: Department of Internal Medicine, Saiseikai Matsusaka General Hospital
– sequence: 19
  fullname: Sugimoto, Tadafumi
  organization: Department of Cardiology, Ise Red Cross Hospital
– sequence: 20
  fullname: Ohnishi, Takahiro
  organization: Department of Nephrology, Ise Red Cross Hospital
– sequence: 21
  fullname: Murata, Tomohiro
  organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine
– sequence: 22
  fullname: Ishikawa, Eiji
  organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine
– sequence: 23
  fullname: Okamoto, Ryuji
  organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine
– sequence: 24
  fullname: Yamada, Tomomi
  organization: Department of Translational Medical Science, Mie University Graduate School of Medicine
– sequence: 25
  fullname: Ogura, Toru
  organization: Clinical Research Support Center, Mie University Hospital
– sequence: 26
  fullname: Nishimura, Yuki
  organization: Clinical Research Support Center, Mie University Hospital
– sequence: 27
  fullname: Tanigawa, Takashi
  organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine
– sequence: 28
  fullname: Nomura, Shinsuke
  organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine
– sequence: 29
  fullname: Nishikawa, Masakatsu
  organization: Institute of Human Research Promotion and Drug Development, Mie University Faculty of Medicine
– sequence: 30
  fullname: Ito, Masaaki
  organization: Department of Cardiology and Nephrology, Mie University Graduate School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29093429$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtr3DAQgEVJaR7tvaeiYy9O9PLaOi7ubtMQSElSehRjWV5rsaWtJAfyS_p3a2c3CeTQi2YGfd8MzJyiI-edQegzJeeU5fxC26C359VVRouMcMnfoRPKRZGJkpGjp3yRyVLwY3Qa45YQJkkuP6DjKUoumDxBf1e68xpCY_0mwK6zGi9jNDEOxiXsW1zNf6DxXQqjTmOAHoNr8Hp0OlnvpnJZOx8G6G2yJmLr8E-YMpci_m1Th1euye4SbAy-NTP-zUYDca60sQ_WbXDVBe-mwZdm8NOs_jHa-BG9b6GP5tMhnqFf69V9dZld33z_US2vM50LmTKzIFA2RanrQtYFE7KhmhdtWwhOWqZrTRlt8oK1TCyAN3UNk8dJI6XgpdCSn6Gv-7674P-MJiY12KhN34MzfoyKylxyxiWhE_rlgI71YBq1C3aA8KielzkBZA_o4GMMpn1BKFHzvdTTvVR1pWih5ntNyuKNom2CebEpgO3_J6734jbOu32ZBCFZ3ZuDUDLF5udVfAU6CMo4_g9wBLek
CitedBy_id crossref_primary_10_2147_IJGM_S359168
crossref_primary_10_1053_j_ackd_2019_10_004
crossref_primary_10_1590_2175_8239_jbn_2021_s104
crossref_primary_10_1016_j_ijcha_2024_101505
crossref_primary_10_3389_fphys_2019_00144
crossref_primary_10_1007_s00380_021_01919_7
crossref_primary_10_1080_0886022X_2021_1885444
crossref_primary_10_1007_s00392_023_02153_z
crossref_primary_10_1253_circj_CJ_19_1036
crossref_primary_10_1111_echo_15728
crossref_primary_10_1111_echo_14413
crossref_primary_10_1016_j_ahj_2022_02_001
crossref_primary_10_4103_heartviews_heartviews_37_23
crossref_primary_10_1016_j_cjca_2019_05_028
crossref_primary_10_1002_clc_23815
crossref_primary_10_1177_0896860820941371
crossref_primary_10_1136_heartjnl_2021_319604
crossref_primary_10_1038_s41598_020_73038_8
crossref_primary_10_14814_phy2_70050
crossref_primary_10_1186_s41100_021_00367_3
crossref_primary_10_1161_CIR_0000000000000979
crossref_primary_10_1016_j_ijcard_2022_01_043
crossref_primary_10_1007_s12574_020_00461_1
crossref_primary_10_1007_s12574_019_00436_x
crossref_primary_10_1007_s10741_023_10376_5
crossref_primary_10_3390_biom13050773
crossref_primary_10_3390_cells10071824
crossref_primary_10_1007_s12410_020_9534_0
crossref_primary_10_3389_fneph_2023_1198560
crossref_primary_10_1093_ehjci_jead020
ContentType Journal Article
Copyright 2018 THE JAPANESE CIRCULATION SOCIETY
Copyright_xml – notice: 2018 THE JAPANESE CIRCULATION SOCIETY
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1253/circj.CJ-17-0393
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1347-4820
EndPage 595
ExternalDocumentID 29093429
10_1253_circj_CJ_17_0393
article_circj_82_2_82_CJ_17_0393_article_char_en
Genre Multicenter Study
Journal Article
GroupedDBID ---
.55
29B
2WC
53G
5GY
5RE
6J9
AAUGY
ACGFO
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
JSF
JSH
KQ8
M~E
OK1
P2P
RJT
RNS
RZJ
TR2
W2D
X7M
XSB
ZXP
.GJ
3O-
AAYXX
CITATION
OVT
TKC
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c549t-e60a8d78cb79b7249d1c37ff7430f2cbc121d572f246a3dbbac5430d994384c93
ISSN 1346-9843
1347-4820
IngestDate Fri Jul 11 00:32:09 EDT 2025
Thu Apr 03 07:00:09 EDT 2025
Tue Jul 01 02:01:22 EDT 2025
Thu Apr 24 23:01:13 EDT 2025
Thu Aug 17 20:29:17 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords End-stage renal disease
Echocardiography
Aortic valve sclerosis
Hemodialysis
Left ventricle
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c549t-e60a8d78cb79b7249d1c37ff7430f2cbc121d572f246a3dbbac5430d994384c93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/circj/82/2/82_CJ-17-0393/_article/-char/en
PMID 29093429
PQID 1959323901
PQPubID 23479
PageCount 10
ParticipantIDs proquest_miscellaneous_1959323901
pubmed_primary_29093429
crossref_primary_10_1253_circj_CJ_17_0393
crossref_citationtrail_10_1253_circj_CJ_17_0393
jstage_primary_article_circj_82_2_82_CJ_17_0393_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-01-25
PublicationDateYYYYMMDD 2018-01-25
PublicationDate_xml – month: 01
  year: 2018
  text: 2018-01-25
  day: 25
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Circulation Journal
PublicationTitleAlternate Circ J
PublicationYear 2018
Publisher The Japanese Circulation Society
Publisher_xml – name: The Japanese Circulation Society
References 5. Losi MA, Memoli B, Contaldi C, Barbati G, Del Prete M, Betocchi S, et al. Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis. Nephrol Dial Transplant 2010; 25: 1950–1954.
21. Rattazzi M, Bertacco E, Del Vecchio A, Puato M, Faggin E, Pauletto P. Aortic valve calcification in chronic kidney disease. Nephrol Dial Transplant 2013; 28: 2968–2976.
22. Cowell SJ, Newby DE, Burton J, White A, Northridge DB, Boon NA, et al. Aortic valve calcification on computed tomography predicts the severity of aortic stenosis. Clin Radiol 2003; 58: 712–716.
23. Davies SW, Gershlick AH, Balcon R. Progression of valvar aortic stenosis: A long-term retrospective study. Eur Heart J 1991; 12: 10–14.
10. Ventura JE, Tavella N, Romero C, Petraglia A, Báez A, Muñoz L. Aortic valve calcification is an independent factor of left ventricular hypertrophy in patients on maintenance haemodialysis. Nephrol Dial Transplant 2002; 17: 1795–1801.
11. Kizer JR, Wiebers DO, Whisnant JP, Galloway JM, Welty TK, Lee ET, et al. Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: The Strong Heart Study. Stroke 2005; 36: 2533–2537.
20. Ribeiro S, Ramos A, Brandão A, Rebelo JR, Guerra A, Resina C, et al. Cardiac valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism. Nephrol Dial Transplant 1998; 13: 2037–2040.
26. Minners J, Allgeier M, Gohlke-Baerwolf C, Kienzle RP, Neumann FJ, Jander N. Inconsistencies of echocardiographic criteria for the grading of aortic valve stenosis. Eur Heart J 2008; 29: 1043–1048.
6. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15: 167–184.
13. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation 2007; 115: 2856–2864.
4. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, et al. Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging 2012; 5: 251–261.
14. Magne J, Mohty D, Boulogne C, Deltreuil M, Cassat C, Echahidi N, et al. Prognostic impact of global left ventricular hemodynamic afterload in severe aortic stenosis with preserved ejection fraction. Int J Cardiol 2015; 180: 158–164.
37. Murata T, Dohi K, Onishi K, Sugiura E, Fujimoto N, Ichikawa K, et al. Role of haemodialytic therapy on left ventricular mechanical dyssynchrony in patients with end-stage renal disease quantified by speckle-tracking strain imaging. Nephrol Dial Transplant 2011; 26: 1655–1661.
30. Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation 1979; 59: 679–688.
1. Michel PL. Aortic stenosis in chronic renal failure patients treated by dialysis. Nephrol Dial Transplant 1998; 13(Suppl 4): 44–48.
34. Heymans S, Schroen B, Vermeersch P, Milting H, Gao F, Kassner A, et al. Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart. Circulation 2005; 112: 1136–1144.
31. Dweck MR, Joshi S, Murigu T, Gulati A, Alpendurada F, Jabbour A, et al. Left ventricular remodeling and hypertrophy in patients with aortic stenosis: Insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012; 14: 50.
18. Farshid A, Pathak R, Shadbolt B, Arnolda L, Talaulikar G. Diastolic function is a strong predictor of mortality in patients with chronic kidney disease. BMC Nephrol 2013; 14: 280.
17. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458.
32. Briand M, Dumesnil JG, Kadem L, Tongue AG, Rieu R, Garcia D, et al. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: Implications for diagnosis and treatment. J Am Coll Cardiol 2005; 46: 291–298.
15. de Simone G. Left ventricular geometry and hypotension in end-stage renal disease: A mechanical perspective. J Am Soc Nephrol 2003; 14: 2421–2427.
2. Ohara T, Hashimoto Y, Matsumura A, Suzuki M, Isobe M. Accelerated progression and morbidity in patients with aortic stenosis on chronic dialysis. Circ J 2005; 69: 1535–1539.
8. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28: 1–39.e14.
12. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009; 22: 1–23; quiz 101–102.
16. Wang H, Liu J, Yao XD, Li J, Yang Y, Cao TS, et al. Multidirectional myocardial systolic function in hemodialysis patients with preserved left ventricular ejection fraction and different left ventricular geometry. Nephrol Dial Transplant 2012; 27: 4422–4429.
27. Iwata S, Hyodo E, Yanagi S, Hayashi Y, Nishiyama H, Kamimori K, et al. Parathyroid hormone and systolic blood pressure accelerate the progression of aortic valve stenosis in chronic hemodialysis patients. Int J Cardiol 2013; 163: 256–259.
35. Codolosa JN, Koshkelashvili N, Alnabelsi T, Goykhman I, Romero-Corral A, Pressman GS. Effect of mitral annular calcium on left ventricular diastolic parameters. Am J Cardiol 2016; 117: 847–852.
7. Masuda C, Dohi K, Sakurai Y, Bessho Y, Fukuda H, Fujii S, et al. Impact of chronic kidney disease on the presence and severity of aortic stenosis in patients at high risk for coronary artery disease. Cardiovasc Ultrasound 2011; 9: 31.
33. Lindsay MM, Maxwell P, Dunn FG. TIMP-1: A marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension 2002; 40: 136–141.
19. Maher ER, Young G, Smyth-Walsh B, Pugh S, Curtis JR. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 1987; 2: 875–877.
9. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107–133.
25. Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis: A disease of the valve and the myocardium. J Am Coll Cardiol 2012; 60: 1854–1863.
3. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, et al. Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling. Clin J Am Soc Nephrol 2013; 8: 2106–2116.
28. Salcedo EE, Korzick DH, Currie PJ, Stewart WJ, Lever HM, Goormastic M. Determinants of left ventricular hypertrophy in patients with aortic stenosis. Cleve Clin J Med 1989; 56: 590–596.
24. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343: 611–617.
29. Kupari M, Turto H, Lommi J. Left ventricular hypertrophy in aortic valve stenosis: Preventive or promotive of systolic dysfunction and heart failure? Eur Heart J 2005; 26: 1790–1796.
36. Dimitrow PP, Michałowska J, Sorysz D. The effect of hemodialysis on left ventricular outflow tract gradient. Echocardiography 2010; 27: 603–607.
22
23
24
25
26
27
28
29
30
31
10
32
11
33
12
34
13
35
14
36
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
References_xml – reference: 31. Dweck MR, Joshi S, Murigu T, Gulati A, Alpendurada F, Jabbour A, et al. Left ventricular remodeling and hypertrophy in patients with aortic stenosis: Insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012; 14: 50.
– reference: 7. Masuda C, Dohi K, Sakurai Y, Bessho Y, Fukuda H, Fujii S, et al. Impact of chronic kidney disease on the presence and severity of aortic stenosis in patients at high risk for coronary artery disease. Cardiovasc Ultrasound 2011; 9: 31.
– reference: 2. Ohara T, Hashimoto Y, Matsumura A, Suzuki M, Isobe M. Accelerated progression and morbidity in patients with aortic stenosis on chronic dialysis. Circ J 2005; 69: 1535–1539.
– reference: 24. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343: 611–617.
– reference: 33. Lindsay MM, Maxwell P, Dunn FG. TIMP-1: A marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension 2002; 40: 136–141.
– reference: 9. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107–133.
– reference: 8. Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28: 1–39.e14.
– reference: 18. Farshid A, Pathak R, Shadbolt B, Arnolda L, Talaulikar G. Diastolic function is a strong predictor of mortality in patients with chronic kidney disease. BMC Nephrol 2013; 14: 280.
– reference: 25. Dweck MR, Boon NA, Newby DE. Calcific aortic stenosis: A disease of the valve and the myocardium. J Am Coll Cardiol 2012; 60: 1854–1863.
– reference: 12. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009; 22: 1–23; quiz 101–102.
– reference: 30. Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation 1979; 59: 679–688.
– reference: 10. Ventura JE, Tavella N, Romero C, Petraglia A, Báez A, Muñoz L. Aortic valve calcification is an independent factor of left ventricular hypertrophy in patients on maintenance haemodialysis. Nephrol Dial Transplant 2002; 17: 1795–1801.
– reference: 17. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 1986; 57: 450–458.
– reference: 36. Dimitrow PP, Michałowska J, Sorysz D. The effect of hemodialysis on left ventricular outflow tract gradient. Echocardiography 2010; 27: 603–607.
– reference: 27. Iwata S, Hyodo E, Yanagi S, Hayashi Y, Nishiyama H, Kamimori K, et al. Parathyroid hormone and systolic blood pressure accelerate the progression of aortic valve stenosis in chronic hemodialysis patients. Int J Cardiol 2013; 163: 256–259.
– reference: 11. Kizer JR, Wiebers DO, Whisnant JP, Galloway JM, Welty TK, Lee ET, et al. Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovascular disease: The Strong Heart Study. Stroke 2005; 36: 2533–2537.
– reference: 21. Rattazzi M, Bertacco E, Del Vecchio A, Puato M, Faggin E, Pauletto P. Aortic valve calcification in chronic kidney disease. Nephrol Dial Transplant 2013; 28: 2968–2976.
– reference: 34. Heymans S, Schroen B, Vermeersch P, Milting H, Gao F, Kassner A, et al. Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart. Circulation 2005; 112: 1136–1144.
– reference: 23. Davies SW, Gershlick AH, Balcon R. Progression of valvar aortic stenosis: A long-term retrospective study. Eur Heart J 1991; 12: 10–14.
– reference: 13. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation 2007; 115: 2856–2864.
– reference: 14. Magne J, Mohty D, Boulogne C, Deltreuil M, Cassat C, Echahidi N, et al. Prognostic impact of global left ventricular hemodynamic afterload in severe aortic stenosis with preserved ejection fraction. Int J Cardiol 2015; 180: 158–164.
– reference: 32. Briand M, Dumesnil JG, Kadem L, Tongue AG, Rieu R, Garcia D, et al. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: Implications for diagnosis and treatment. J Am Coll Cardiol 2005; 46: 291–298.
– reference: 1. Michel PL. Aortic stenosis in chronic renal failure patients treated by dialysis. Nephrol Dial Transplant 1998; 13(Suppl 4): 44–48.
– reference: 22. Cowell SJ, Newby DE, Burton J, White A, Northridge DB, Boon NA, et al. Aortic valve calcification on computed tomography predicts the severity of aortic stenosis. Clin Radiol 2003; 58: 712–716.
– reference: 35. Codolosa JN, Koshkelashvili N, Alnabelsi T, Goykhman I, Romero-Corral A, Pressman GS. Effect of mitral annular calcium on left ventricular diastolic parameters. Am J Cardiol 2016; 117: 847–852.
– reference: 20. Ribeiro S, Ramos A, Brandão A, Rebelo JR, Guerra A, Resina C, et al. Cardiac valve calcification in haemodialysis patients: Role of calcium-phosphate metabolism. Nephrol Dial Transplant 1998; 13: 2037–2040.
– reference: 3. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, et al. Effects of frequent hemodialysis on ventricular volumes and left ventricular remodeling. Clin J Am Soc Nephrol 2013; 8: 2106–2116.
– reference: 5. Losi MA, Memoli B, Contaldi C, Barbati G, Del Prete M, Betocchi S, et al. Myocardial fibrosis and diastolic dysfunction in patients on chronic haemodialysis. Nephrol Dial Transplant 2010; 25: 1950–1954.
– reference: 6. Quinones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA. Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002; 15: 167–184.
– reference: 28. Salcedo EE, Korzick DH, Currie PJ, Stewart WJ, Lever HM, Goormastic M. Determinants of left ventricular hypertrophy in patients with aortic stenosis. Cleve Clin J Med 1989; 56: 590–596.
– reference: 29. Kupari M, Turto H, Lommi J. Left ventricular hypertrophy in aortic valve stenosis: Preventive or promotive of systolic dysfunction and heart failure? Eur Heart J 2005; 26: 1790–1796.
– reference: 26. Minners J, Allgeier M, Gohlke-Baerwolf C, Kienzle RP, Neumann FJ, Jander N. Inconsistencies of echocardiographic criteria for the grading of aortic valve stenosis. Eur Heart J 2008; 29: 1043–1048.
– reference: 16. Wang H, Liu J, Yao XD, Li J, Yang Y, Cao TS, et al. Multidirectional myocardial systolic function in hemodialysis patients with preserved left ventricular ejection fraction and different left ventricular geometry. Nephrol Dial Transplant 2012; 27: 4422–4429.
– reference: 4. Chan CT, Greene T, Chertow GM, Kliger AS, Stokes JB, Beck GJ, et al. Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials. Circ Cardiovasc Imaging 2012; 5: 251–261.
– reference: 19. Maher ER, Young G, Smyth-Walsh B, Pugh S, Curtis JR. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 1987; 2: 875–877.
– reference: 15. de Simone G. Left ventricular geometry and hypotension in end-stage renal disease: A mechanical perspective. J Am Soc Nephrol 2003; 14: 2421–2427.
– reference: 37. Murata T, Dohi K, Onishi K, Sugiura E, Fujimoto N, Ichikawa K, et al. Role of haemodialytic therapy on left ventricular mechanical dyssynchrony in patients with end-stage renal disease quantified by speckle-tracking strain imaging. Nephrol Dial Transplant 2011; 26: 1655–1661.
– ident: 2
– ident: 18
– ident: 4
– ident: 12
– ident: 35
– ident: 33
– ident: 10
– ident: 16
– ident: 14
– ident: 31
– ident: 28
– ident: 24
– ident: 9
– ident: 7
– ident: 20
– ident: 26
– ident: 22
– ident: 17
– ident: 3
– ident: 5
– ident: 1
– ident: 36
– ident: 11
– ident: 19
– ident: 34
– ident: 13
– ident: 15
– ident: 32
– ident: 29
– ident: 30
– ident: 6
– ident: 8
– ident: 21
– ident: 27
– ident: 25
– ident: 23
SSID ssj0029059
Score 2.3863556
Snippet Background:The aim of this study was to assess the echocardiographic characteristics of chronic hemodialysis (HD) patients with end-stage renal disease (ESRD)...
The aim of this study was to assess the echocardiographic characteristics of chronic hemodialysis (HD) patients with end-stage renal disease (ESRD) in a...
SourceID proquest
pubmed
crossref
jstage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 586
SubjectTerms Aged
Aortic valve sclerosis
Aortic Valve Stenosis
Calcinosis
Echocardiography
Echocardiography - methods
End-stage renal disease
Heart Defects, Congenital - diagnostic imaging
Hemodialysis
Humans
Kidney Failure, Chronic - complications
Left ventricle
Middle Aged
Mitral Valve - pathology
Parathyroid Hormone - blood
Prospective Studies
Renal Dialysis
Risk Factors
Ventricular Function, Left
Title Echocardiographic Assessment of Cardiac Structural and Functional Abnormalities in Patients With End-Stage Renal Disease Receiving Chronic Hemodialysis
URI https://www.jstage.jst.go.jp/article/circj/82/2/82_CJ-17-0393/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/29093429
https://www.proquest.com/docview/1959323901
Volume 82
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Circulation Journal, 2018/01/25, Vol.82(2), pp.586-595
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwEDa7C0JcEK-F8pKRuKAqu4nzPqGq6qqqtIhDV-otip2EZh8JapMD_BH-LjO242R3KWK5RG1qO2nmi2c8nvmGkI88EqBIgswC3YELlIxZaZCHVub6RewXqRNxzB0-_RLMz7zFyl_t7d8bRC21DT8SP_-YV_I_UoVzIFfMkr2DZM2gcAI-g3zhCBKG4z_JeAZzl5ABpZJ3uhTjiSHaVIlXKH6BW8-tUAQb6Cc_AV2mXYATXqHReil5VdH38VXxrGJYbLMez6rMAnP0GxZ3qOQEKbdz0NjMS-mK0OS6oL6uasxBQYKTocE7LTdCVwgzLBW7qCvQBl6A8saimONhRx1a2nvPm20rXbzzEpT8ujTWeL1WwQlpvWkHvvZ1maVd86K9Mu2X6UWOxWDUb1n-o70oh24QByPwLJUyrWdu1wusOFKcT0d5dy60vIjZw-k-YgNYs8Hc7Xec3Oqbqv15S8MwWSZEwDM4P5ouLNDxmN3ca9MuguCGkjWhj7jogjESOUIyXSROmOAI--Q-g5WOzFdfmSglFtuy3p_5d3qnHUY4vnkP1yyrB-fbRrJG7Fo3Sftp-YQ81gsfOlEofkr28uoZeXiqQzuek1-3wEx7MNO6oBrMtAczBTDTHsz0GphpWdEOzBTBTA2YqQQz1WCmBsxUg5kOwfyCnJ3MltO5pauGWML34sbKAzuNsjASPIx5yLw4c4QbFgWYynbBBBcOczI_ZAXzgtTNOE-hn2tncey5kSdi95AcVHWVvyI0i2wOz9yOBRjahS-44wvfDRwwVgrB_XhEjrsnDvJUoTNY2eUy2SXlEflkenxXdDJ_aftZCdG01BONbhmxhOGh79E3WKcbmCBH5EMn_QS0Bm4Fwitct9sEKaVchv7OEXmpYGGuApiLXTBTX9_hXt-QR_1L-ZYcABLyd2CtN_y9xPNvVrn0TA
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Echocardiographic+Assessment+of+Cardiac+Structural+and+Functional+Abnormalities+in+Patients+With+End-Stage+Renal+Disease+Receiving+Chronic+Hemodialysis&rft.jtitle=Circulation+journal+%3A+official+journal+of+the+Japanese+Circulation+Society&rft.au=Matsuo%2C+Hiroshi&rft.au=Dohi%2C+Kaoru&rft.au=Machida%2C+Hirofumi&rft.au=Takeuchi%2C+Hideyuki&rft.date=2018-01-25&rft.issn=1346-9843&rft.eissn=1347-4820&rft.volume=82&rft.issue=2&rft.spage=586&rft.epage=595&rft_id=info:doi/10.1253%2Fcircj.CJ-17-0393&rft.externalDBID=n%2Fa&rft.externalDocID=10_1253_circj_CJ_17_0393
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1346-9843&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1346-9843&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1346-9843&client=summon